The Clinical Value of MRI Testing in Prostate Cancer

Andrew Vickers, PhD, attending research methodologist at Memorial Sloan Kettering Cancer Center, discusses the clinical value of MRI testing in prostate cancer.

Vickers says that, as of now, the most valuable clinical benefit of MRI is to find the cancers that TRUS biopsies miss. More of these clinically significant cancers are found with MRI, though the long-term effects of these cancers are still largely unkown.